Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Jul;91 Suppl 1(Suppl 1):101639.
doi: 10.1016/j.bjorl.2025.101639. Epub 2025 Jun 4.

Sentinel lymph node biopsy in early oral cavity tumors: Evaluation of the oncologic efficacy compared to elective neck dissection

Affiliations
Comparative Study

Sentinel lymph node biopsy in early oral cavity tumors: Evaluation of the oncologic efficacy compared to elective neck dissection

Marco Roberto Seferin et al. Braz J Otorhinolaryngol. 2025 Jul.

Abstract

Objective: To describe the oncological results of a prospective study in the use of sentinel lymph node biopsy as part of the surgical treatment of squamous cell carcinoma T1/T2N0 of the oral cavity in comparison to the results of patients submitted to levels I, II and III SND.

Methods: It was a prospective study in which seventy patients were divided into two groups, 35 being submitted to SND and the other 35 to SLB.

Results: In the SND group, locoregional recurrence occurred in 17.1%, with a 2.9% development of distant metastasis and 8.8% evolved with a second primary tumor. In the SLB, locoregional recurrence was observed in 7 patients (20.0%), 5.7% developed distant metastasis, and 5.7% had a second primary tumor. There was no significant difference between the two groups for both overall (p = 0.521) and disease-free survival (p = 0.753).

Conclusion: A SLB is reliable for the management of clinically negative neck in patients with oral T1/T2N0 squamous cell carcinoma.

Level of evidence: Level III.

Keywords: Lymphatic metastasis; Mouth neoplasms; Prognosis; Sentinel lymph node biopsy; Survival.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Cumulative overall survival of 57.6% for the SND group and 69.7% for the SLB (p = 0.521 ‒ Log-Rank test).
Fig. 2
Fig. 2
Cumulative disease-free survival of 73.0% for the SND group and 71.5% for the SLB group (p = 0.753 ‒ Log-Rank test).
Fig. 3
Fig. 3
ROC curve for the diagnostic evaluation of sentinel lymph node biopsy in patients with squamous cell carcinoma of the oral cavity. Area under the ROC curve = 0.889 (95% CI 0.734%‒0.970%).

References

    1. Huber M., Tantiwongkosi B. Oral and oropharyngeal cancer. Med Clin North Am. 2014;98:1299–1321. - PubMed
    1. Argiris A., Karamouzis M.V., Raben D., Ferris R.L. Head and neck cancer. Lancet. 2008;371:1695–1709. - PMC - PubMed
    1. Ferlito A., Silver C.E., Rinaldo A. Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies. Br J Oral Maxillofac Surg. 2009;47:5–9. - PubMed
    1. Kuriakose M.A., Trivedi N.P. Sentinel node biopsy in head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2009;17:100–110. - PubMed
    1. d’Alessandro A.F., Pinto F.R., Lin C.S., et al. Oral cavity squamous cell carcinoma: factors related to occult lymph node metastasis. Braz J Otorhinolaryngol. 2015;81:248–254. - PMC - PubMed

Publication types

MeSH terms